Filter Results:
(1,248)
Show Results For
- All HBS Web
(1,248)
- People (5)
- News (172)
- Research (929)
- Events (6)
- Multimedia (12)
- Faculty Publications (759)
Show Results For
- All HBS Web
(1,248)
- People (5)
- News (172)
- Research (929)
- Events (6)
- Multimedia (12)
- Faculty Publications (759)
Arjun Goyal
on the boards of Scorpion Therapeutics, Quanta Therapeutics, Alterome Therapeutics, Halda Therapeutics, Third Arc Bio, and Centessa Pharmaceuticals (NASDAQ: CNTA) and as a co-founder and director, Affini-T Therapeutics. Furthermore, he... View Details
Keywords: Finance
Arjun Goyal
a director on the boards of Scorpion Therapeutics, Quanta Therapeutics, Affini-T and Centessa Pharmaceuticals (NASDAQ: CNTA) and has played key roles in Vida Venture’s investments in Homology Medicines (NASDAQ:FIXX), Pionyr... View Details
- Portrait Project
Mickey Millar
roach. Each incident left a stain on my spirit. While studying social welfare at HKS, I worked part-time so my pregnant sister wouldn't become homeless after she lost her job while on bed rest. During pharmaceutical case discussions at... View Details
- Fast Answer
Patent search: Product-associated patents
face="Open Sans"> Check company website. Some companies may lists patents associated with their products on their websites. For View Details
- 03 Dec 2024
- News
From One to Many
created with Ferrazzi Greenlight? When I went to HBS I was known as the guy who came out of manufacturing, having spent a number of years implementing Total Quality Management at a pharmaceutical company in Wilmington, Delaware. I reached... View Details
- 04 Feb 2019
- Blog Post
Presenting…an Alternative to Company Presentations: Evercore Grabs Attention with Interactive Events
case study. When they added two more ingredients to the recipe – a focus on a familiar industry, amplified by media exposure the audience would recognize – they arrived at the heart of their presentation; a “live” case study about Evercore’s role in a recent M&A:... View Details
- 01 Oct 1998
- News
Going Against the Flow
500 automobile, chemical, and pharmaceutical companies that actually run businesses here. Those latter companies know the market and have done very well as a result. "If you're going to invest in emerging markets," he continues, "you also... View Details
Keywords: Dun Gifford, Jr.
- 11 Sep 2019
- Research & Ideas
Germany May Have the Answer for Reducing Drug Prices
the Poronui Associate Professor of Business Administration. Pharmaceutical companies have long opposed efforts to regulate drug prices, arguing that prices reflect the companies’ massive research investments. But Germany’s approach shows... View Details
- 01 Dec 2004
- News
Capitalizing Poetry
Barr Photo courtesy Poetry Foundation In 2002, pharmaceutical heiress Ruth Lilly made a gift in excess of $100 million to the Modern Poetry Association (now the renamed Poetry Foundation). Tapped in February to figure out what to do with... View Details
- 06 May 2008
- First Look
First Look: May 6, 2008
company which had been put up for sale by pharmaceutical giant Pfizer. Examining the decision from a strategic perspective, the (A) case provides brief histories of the two companies; traces the global confectionery industry, focusing... View Details
Keywords: Martha Lagace
- 23 Mar 2010
- First Look
First Look: March 23
catastrophic risks to patients, physicians, pharmaceutical firms, and regulators. Between the early 1960s and the present, national systems were built to collect, standardize, and respond to individual reports of side effects, with the... View Details
Keywords: Martha Lagace
- 01 Oct 1998
- News
Playing to Win
in turning losing teams into winners, Louis-Dreyfus has an enviable record of reshaping underperforming companies into formidable competitors. A scion of one of France's most prominent business families, he rejuvenated IMS International, a struggling U.S. View Details
Keywords: Garry Emmons
- 15 Apr 2014
- News
Bertarelli Foundation Gift Names Deans' Health & Life Sciences Challenge Prize
entrepreneur who has had a successful career in business, finance, yachting, and philanthropy. He is the former CEO of Serono SA (formerly known Ares-Serono), a family-controlled global pharmaceuticals and biotechnology leader whose roots... View Details
- 11 Aug 2003
- Research & Ideas
Cheap, Fast, and In Control: How Tech Aids Innovation
experimentation and are triggering fundamental changes in R&D processes and performance in such fields as integrated circuit design, automotive development, and pharmaceutical drug discovery. Computer modeling and simulation, rapid... View Details
Keywords: by Wendy Guild
- 23 Aug 2020
- News
In the UK, She Leads the Search for a COVID Vaccine
told the Daily Mail. In fact, Bingham’s role—working with pharmaceutical firms, planning manufacturing facilities, and making investment decisions—ties in directly with her career experience. “As a venture capitalist, I have to write a... View Details
- 26 Jul 2016
- Working Paper Summaries
The Impact of the Entry of Biosimilars: Evidence from Europe
- 26 Apr 2004
- Research & Ideas
A Clear Eye for Innovation
is Ciba Vision. Established in the early 1980s as a unit of the Swiss pharmaceutical giant Ciba-Geigy (now Novartis), the Atlanta-based Ciba Vision sells contact lenses and related eye-care products to optometrists and consumers. Although... View Details
- 01 Feb 2002
- News
Telling the Electronic Century's Unfinished Story
and pharmaceutical industries. But the differences between those pairs of sectors were just too great. So the second book will examine this question: Why were the Japanese chemical and pharmaceutical... View Details
- 09 Feb 2018
- Working Paper Summaries